A reverse-translational approach to bipolar disorder: rodent and human studies in the Behavioral Pattern Monitor.
Mania is the defining feature of bipolar disorder (BD). There has been limited progress in understanding the neurobiological underpinnings of BD mania and developing novel therapeutics, in part due to a paucity of relevant animal models with translational potential. Hyperactivity is a cardinal symptom of mania, traditionally measured in humans using observer-rated scales. Multivariate assessment of unconditioned locomotor behavior using the rat Behavioral Pattern Monitor (BPM) developed in our laboratory has shown that hyperactivity includes complex multifaceted behaviors. The BPM has been used to demonstrate differential effects of drugs on locomotor activity and exploratory behavior in rats. Studies of genetically engineered mice in a mouse BPM have confirmed its utility as a cross-species tool. In a "reverse-translational" approach to this work, we developed the human BPM to characterize motor activity in BD patients. Increased activity, object interactions, and altered locomotor patterns provide multi-dimensional phenotypes to model in the rodent BPM. This unique approach to modeling BD provides an opportunity to identify the neurobiology underlying BD mania and test novel antimanic agents.
Young
Jared W
JW
University of California San Diego, Department of Psychiatry, 9500 Gilman Dr., La Jolla, CA 92093-0603, USA.
Minassian
Arpi
A
Paulus
Martin P
MP
Geyer
Mark A
MA
Perry
William
W
D000818:Animals; D035841:Behavioral Research / Q000295:instrumentation; D001714:Bipolar Disorder / Q000150:complications* / Q000175:diagnosis / Q000503:physiopathology; D002491:Central Nervous System Agents / Q000494:pharmacology; D004195:Disease Models, Animal; D005106:Exploratory Behavior / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D006948:Hyperkinesis / Q000139:chemically induced / Q000150:complications* / Q000503:physiopathology; D051379:Mice; D018670:Monitoring, Ambulatory / Q000295:instrumentation; D009043:Motor Activity / Q000187:drug effects / Q000502:physiology*; D010363:Pattern Recognition, Automated; D051381:Rats
D002491:Central Nervous System Agents
Dev Psychobiol. 1997 Sep;31(2):137-42
9298639
Harv Rev Psychiatry. 1995 May-Jun;3(1):18-35
9384925
Eur J Pharmacol. 1998 Feb 19;343(2-3):135-43
9570460
Psychopharmacology (Berl). 1998 Nov;140(1):69-74
9862404
Neuron. 1999 Mar;22(3):581-91
10197537
Psychopharmacology (Berl). 1999 May;144(1):61-6
10379625
Brain Res. 1999 Jul 17;835(1):18-26
10448192
Brain Res. 1999 Jul 17;835(1):27-36
10448193
Psychopharmacology (Berl). 2001 Jul;156(2-3):117-54
11549216
Neurosci Biobehav Rev. 2001 Jul;25(5):409-26
11566479
Behav Brain Res. 2001 Nov 1;125(1-2):127-32
11682103
Behav Brain Res. 2002 Mar 10;130(1-2):103-9
11864725
Mol Psychiatry. 2002;7(10):1039-53
12476318
Biol Psychiatry. 2003 Feb 15;53(4):352-9
12586455
Behav Neurosci. 2003 Jun;117(3):464-77
12802875
J Clin Psychiatry. 2003 Jun;64(6):680-90; quiz 738-9
12823083
Neuropsychopharmacology. 2004 Feb;29(2):221-8
14603268
Eur Psychiatry. 2004 Feb;19(1):8-14
14969775
Psychopharmacology (Berl). 2004 May;173(3-4):310-7
14747902
J Exp Child Psychol. 1969 Oct;8(2):271-83
5356738
Psychopharmacologia. 1975 Oct 14;44(1):47-51
1197579
Pharmakopsychiatr Neuropsychopharmakol. 1975 Jan;8(1):45-50
1233511
Behav Brain Res. 2005 Sep 8;163(2):212-8
15979169
Genes Brain Behav. 2006 Feb;5(1):85-95
16436192
J Psychopharmacol. 2006 Sep;20(5):714-22
16401660
J Neuropsychiatry Clin Neurosci. 2006 Summer;18(3):296-301
16963579
Neuropsychopharmacology. 2006 Nov;31(11):2349-58
16855533
Neuropharmacology. 2007 Feb;52(2):634-45
17097694
Pharmacol Ther. 2007 May;114(2):222-32
17395264
Psychol Bull. 1976 May;83(3):482-504
17582919
Pharmacol Ther. 1999 Nov;84(2):133-56
10596903
Psychol Med. 1999 Nov;29(6):1307-21
10616937
Biol Psychiatry. 2000 Sep 15;48(6):486-504
11018222
J Neurosci. 2000 Nov 1;20(21):8138-43
11050136
J Neurosci. 2001 Jan 1;21(1):305-13
11150348
J Nerv Ment Dis. 2001 Jan;189(1):8-16
11206670
Behav Brain Res. 2001 Jan 8;118(1):95-105
11163638
Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1982-7
11172062
Am J Med Genet. 2001 Mar 8;105(2):145-51
11304827
Biol Psychiatry. 2001 Apr 15;49(8):655-64
11313033
J Pharmacol Exp Ther. 2001 Jul;298(1):148-55
11408536
Psychopharmacology (Berl). 1977 Nov 24;55(1):67-74
414263
Pharmacol Biochem Behav. 1979 Jul;11(1):23-30
493296
J Pharm Pharmacol. 1979 Sep;31(9):611-4
41063
Pharmacol Biochem Behav. 1980 Apr;12(4):603-8
7393956
Brain Res. 1982 Mar;257(1):137-47
6120751
Psychopharmacology (Berl). 1982;77(2):179-85
6812137
Biol Psychiatry. 1983 Sep;18(9):989-1005
6416309
Neurosci Biobehav Rev. 1984 Spring;8(1):153-9
6145135
Behav Neural Biol. 1984 Jul;41(2):200-8
6541475
Pharmacol Biochem Behav. 1984 Dec;21(6):871-5
6522417
Arch Gen Psychiatry. 1985 Mar;42(3):288-94
3977548
Neuroscience. 1985 Mar;14(3):783-98
2986045
Pharmacol Biochem Behav. 1986 Jul;25(1):277-88
2875472
Mol Pharmacol. 1986 Nov;30(5):427-36
3534542
Prog Neuropsychopharmacol Biol Psychiatry. 1986;10(6):755-61
3809527
Pharmacol Biochem Behav. 1987 Jan;26(1):195-8
3104932
Pharmacol Biochem Behav. 1987 Nov;28(3):393-9
3685075
Toxicology. 1988 May;49(2-3):433-9
3376141
J Pharmacol Exp Ther. 1988 Nov;247(2):547-55
2903234
Dev Psychobiol. 1988 Nov;21(7):679-710
3234601
Behav Brain Res. 1989 Sep 1;34(3):199-211
2789700
Proc Natl Acad Sci U S A. 1990 Jan;87(2):723-7
1967830
Behav Brain Res. 1990 Jan 1;36(1-2):161-70
2302316
Neuropharmacology. 1991 Jun;30(6):629-36
1922682
Pharmacol Biochem Behav. 1991 May;39(1):61-70
1924514
Prog Neuropsychopharmacol Biol Psychiatry. 1991;15(6):903-19
1684875
Compr Psychiatry. 1992 Mar-Apr;33(2):115-20
1347497
Neuropsychopharmacology. 1992 Aug;7(1):15-31
1355968
Behav Brain Res. 1993 Feb 26;53(1-2):11-20
8466655
Psychopharmacology (Berl). 1993;113(2):177-86
7855179
Clin Neurosci. 1995;3(2):131-9
7583619